The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer

被引:297
|
作者
Rosenzweig, KE
Hanley, J
Mah, D
Mageras, G
Hunt, M
Toner, S
Burman, C
Ling, CC
Mychalczak, B
Fuks, Z
Leibel, SA
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2000年 / 48卷 / 01期
关键词
non-small-cell lung cancer; radiotherapy; deep inspiration breath-hold; respiration;
D O I
10.1016/S0360-3016(00)00583-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Conventional radiotherapeutic techniques are associated,vith lung toxicity that limits the treatment dose. Motion of the tumor during treatment requires the use of large safety margins that affect the feasibility of treatment. To address the control of tumor motion and decrease the volume of normal lung irradiated, we investigated the use of three-dimensional conformal radiation therapy (3D-CRT) in conjunction with the deep inspiration breath-hold (DIBH) technique. Methods and Materials: In the DIBH technique, the patient is initially maintained at quiet tidal breathing, followed by a deep inspiration, a deep expiration, a second deep inspiration, and breath-hold. At this point the patient is at approximately 100% vital capacity, and simulation, verification, and treatment take place during this phase of breath-holding. Results: Seven patients have received a total of 164 treatment sessions and have tolerated the technique well. The estimated normal tissue complication probabilities decreased in all patients at their prescribed dose when compared to free breathing. The dose to which patients could be treated with DIBH increased on average from 69.4 Gy to 87.9 Gy, without increasing the risk of toxicity. Conclusions: The DIBH technique provides an advantage to conventional free-breathing treatment by decreasing lung density, reducing normal safety margins, and enabling more accurate treatment. These improvements contribute to the effective exclusion of normal lung tissue from the high-dose region and permit the use of higher treatment doses without increased risks of toxicity. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [41] An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer
    L M Forrest
    D C McMillan
    C S McArdle
    D J Dunlop
    British Journal of Cancer, 2005, 93 : 977 - 978
  • [42] Reproducibility of surface-based deep inspiration breath-hold technique for lung stereotactic body radiotherapy on a closed-bore gantry linac
    Nguyen, Daniel
    Reinoso, Rebeca
    Farah, Jad
    Yossi, Sena
    Lorchel, Fabrice
    Passerat, Victor
    Louet, Estelle
    Pouchard, Isabelle
    Khodri, Mustapha
    Barbet, Nicolas
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 26
  • [43] Treatment Outcome and Lung Toxicities of Volumetric Modulated Arc Therapy in the Treatment of Inoperable Non-Small-Cell Lung Cancer Patients
    Xie, C.
    Jin, X.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2181 - S2181
  • [44] Clinical benefits of deep inspiration breath-hold in postoperative radiotherapy for right-sided breast cancer: a meta-analysis
    Li, Zhuocheng
    Jian, Chenxi
    Li, Yuanyuan
    Pan, Zhenyu
    Yang, Guozi
    Sun, Xingru
    BMC CANCER, 2024, 24 (01)
  • [45] Selumetinib in the treatment of non-small-cell lung cancer
    Bernabe, Reyes
    Patrao, Ana
    Carter, Louise
    Blackhall, Fiona
    Dean, Emma
    FUTURE ONCOLOGY, 2016, 12 (22) : 2545 - 2560
  • [46] Surgical treatment of non-small-cell lung cancer
    Schuhan, C.
    Dienemann, H.
    ONKOLOGE, 2011, 17 (08): : 684 - +
  • [47] Gefitinib for non-small-cell lung cancer treatment
    D'Incecco, Armida
    Cappuzzo, Federico
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
  • [48] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [49] Dosimetric evaluation of modern radiation therapy techniques for left breast in deep-inspiration breath-hold
    Koivumakia, Tuomas
    Fogliata, Antonella
    Zeverino, Michele
    Boman, Eeva
    Sierpowska, Joanna
    Moeckli, Raphael
    Vallet, Veronique
    Cozzi, Luca
    Heikkila, Janne
    Vaananen, Anssi
    Vuolukka, Kristiina
    Sillanmaki, Saara
    Seppala, Jan
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 45 : 82 - 87
  • [50] Trastuzumab for the treatment of non-small-cell lung cancer
    Ferrone, M
    Motl, SE
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1904 - 1908